Scientists Built a Womb in a Lab — to Understand Why Pregnancies Fail
Why do IVF embryos sometimes fail to implant even when they’re genetically healthy?
The implantation window — the brief period when the uterine lining becomes receptive to an embryo — lasts just four to six days in each menstrual cycle. Outside that window, the uterus rejects even a genetically perfect embryo. What happens at the cellular level during those days is poorly understood, largely because ethical restrictions make direct research in living women extremely difficult.
Researchers publishing in eLife have developed a ‘window-of-implantation assembloid’ — a three-dimensional tissue model built from human cells that reproduces the receptive uterine environment. Assembloids are more sophisticated than standard cell cultures: they combine multiple cell types and have spatial organization that more closely resembles real tissue. This particular model, called a WOI assembloid, is specifically designed to mimic the endometrium during the implantation window.
What the model captures
The WOI assembloid reproduces the molecular signature of a receptive endometrium: specific proteins that appear and disappear on schedule, changes in cell surface properties that enable embryo adhesion, and signaling pathways active in real uterine tissue during the window. That means the model can serve as a platform for testing which molecular factors open or close the window — without experiments involving women.
This has direct relevance for reproductive medicine. Recurrent implantation failure — where IVF embryos repeatedly fail to implant despite good embryo quality — affects a substantial proportion of IVF patients, and the cause remains unexplained in many cases. A model that reliably reproduces uterine receptivity gives researchers a new tool for investigating that.
Aging and fertility
The longevity connection is less obvious but real. Fertility declines with age, and part of that decline is not embryo-related but reflects changes in the uterine lining itself. How the endometrium ages — and whether that process is modifiable — is a relatively unexplored area. The WOI assembloid makes it possible, for the first time, to investigate that question in a controlled, ethically tractable way.
Whether models like this will eventually lead to treatments that extend or strengthen the implantation window is unknown. As a tool for fundamental research into how human tissue functions and ages, however, this is a meaningful advance — and one that may matter more broadly than its reproductive medicine framing suggests.